Active Not RecruitingNCT07267507
About this title
Accessory Movements and Associated Factors During Active Cervical Range of Motion
Read the official source — NCT07267507Official study titleAccessory Movements and Associated Factors During Active Cervical Range of Motion
This study is no longer accepting new participants.
In AnkaraDepressionObservational studyAges 18–35
- Countries
- Türkiye
- Sponsor
- Atılım University
CompletedNCT07553130
Official study titleValidation of the acceXible Screening and Monitoring System for Depression and Anxiety in the Student Population of the Benemérita Universidad Autónoma de Puebla (BUAP)
This study has finished and is no longer accepting participants.
In Puebla CityDepression, AnxietyObservational studyAges 16–25
- Countries
- Mexico
- Sponsor
- Accexible
CompletedNCT03496285
Official study titleMultimodal MRI Study of Accumbofrontal Tract in Anorexia Nervosa and Obessional Compulsive Disorder : Search for Structural and Functional Changes Between Orbito-frontal Cortex and Accumbens Nucleus Subdivisions
This study has finished and is no longer accepting participants.
In PoitiersEating disordersInterventional studyAges 18–65
- Countries
- France
- Sponsor
- Poitiers University Hospital
CompletedNCT05731557
Official study titleACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life
This study has finished and is no longer accepting participants.
In CamdenAddictionObservational studyAges 18+
- Countries
- United States
- Sponsor
- The Cooper Health System
CompletedNCT02108990
Official study titleAcetaminophen and Social Pain in Borderline Personality Disorder
This study has finished and is no longer accepting participants.
In ColumbusPersonality disordersMedication studyAges 18–50
- Countries
- United States
- Sponsor
- Ohio State University
CompletedNCT02008292
This study has finished and is no longer accepting participants.
In New HavenSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT02169271
Official study titleA Randomized Phase II Trial of Low Dose Aspirin Versus Placebo in High-Risk Individuals With CT-Detected Subsolid Lung Nodules
This study has finished and is no longer accepting participants.
Multiple locations, including HoustonAddictionMedication studyAges 50+
- Countries
- United States, Italy
- Sponsor
- National Cancer Institute (NCI)
Active Not RecruitingNCT06682468
This study is no longer accepting new participants.
In ChicagoAddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of Chicago
CompletedNCT00534781
Official study titleRadiofrequency-based Plasma Microdebridement Compared to Surgical Microdebridement for Treating Achilles Tendinosis: A Prospective, Randomized, Controlled Multi-Center Study"
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimoreBipolarityDevice studyAges 18+
- Countries
- United States
- Sponsor
- ArthroCare Corporation
CompletedNCT00178906
About this title
Acoustical Properties of Speech as Indicators of Suicidal Risk
Read the official source — NCT00178906Official study titleAcoustical Properties of Speech as Indicators of Suicidal Risk
This study has finished and is no longer accepting participants.
In NashvilleDepressionObservational studyAges 25–65
- Countries
- United States
- Sponsor
- Vanderbilt University
CompletedNCT00490516
About this title
ACP-104 in Acutely Psychotic Subjects With Schizophrenia
Read the official source — NCT00490516What is this study about?Researchers compared ACP-104 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
Enrolling By InvitationNCT06194799
Official study titleA 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's Disease Psychosis
This study is by invitation only.
Multiple locations, including Costa MesaSchizophreniaMedication studyAges 55–95
- Countries
- United States, France, Brazil, + 9 others
- Sponsor
- ACADIA Pharmaceuticals Inc.